Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Biopharmaceuticals are a rapidly evolving class of therapeutic agents derived from biological sources, including proteins, nucleic acids, and cells. Unlike traditional pharmaceuticals, which are typically chemically synthesized, biopharmaceuticals are produced using biotechnological methods such as recombinant DNA technology and cell culture. These drugs include monoclonal antibodies, vaccines, therapeutic proteins (like insulin and growth hormones), and gene therapies. Biopharmaceuticals offer targeted treatment options, often with fewer side effects compared to conventional drugs. They play a crucial role in treating complex diseases such as cancer, autoimmune disorders, and rare genetic conditions. The field is continually advancing with innovations in biologics and personalized medicine, promising more effective and individualized treatment strategies.